Cataract Surgery Outcomes in Patients With Axenfeld-Rieger Syndrome.
Summary
Cataract surgery and intraocular lens implantation in patients with ARS is safe, but visual improvement depends on comorbid conditions.
Abstract
PURPOSE
To analyze the outcomes of phacoemulsification with intraocular lens (IOL) implantation in patients with Axenfeld-Rieger syndrome (ARS).
METHODS
This was a retrospective observational study. Patients with ARS who underwent cataract surgery and had a minimum postoperative follow-up of 6 weeks were included. Visual outcomes after cataract surgery and complications were evaluated in these patients.
RESULTS
All patients underwent uneventful cataract surgery. A total of 12 eyes of 11 patients were included, 6 males and 5 females. The mean age was 45.3 ± 10.5 years, and the mean follow-up period was 21.6 months. The mean best-corrected visual acuity (BCVA) preoperatively was 0.9 ± 0.3 Log MAR and postoperatively was 0.4 ± 0.3 LogMAR (P = 0.0043). Eleven patients had secondary glaucoma requiring surgical intervention in 6/12 eyes (50%). Two patients required Descemet stripping automated endothelial keratoplasty (DSAEK) postcataract surgery for corneal decompensation. No significant intraoperative complications occurred in these patients.
CONCLUSIONS
Cataract surgery and intraocular lens implantation in patients with ARS is safe, but visual improvement depends on comorbid conditions.
Keywords
Top Research in Glaucoma Surgery
Browse all →Treatment Outcomes in the Primary Tube Versus Trabeculectomy Study after 1 Year of Follow-up.
Efficacy, Safety, and Risk Factors for Failure of Standalone Ab Interno Gelatin Microstent Implantation versus Standalone Trabeculectomy.
Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.